Bridgeway Capital Management’s Gossamer Bio GOSS Stock Holding History

Bridgeway Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,000	Closed	-$5.26K	–	1269
2026 Q1	$5.26K	Sell	16,000 -160,000	-91%	-$251K	﹤0.01%	1220
2025 Q4	$546K	Sell	176,000 -159,900	-48%	-$456K	0.01%	806
2025 Q3	$883K	Sell	335,900 -150,000	-31%	-$331K	0.02%	717
2025 Q2	$598K	Sell	485,900 -75,000	-13%	-$81.8K	0.01%	742
2025 Q1	$617K	Buy	560,900 +19,900	+4%	+$23K	0.02%	709
2024 Q4	$489K	Sell	541,000 -11,000	-2%	-$9.43K	0.01%	823
2024 Q3	$544K	Hold	552,000	–	–	0.01%	843
2024 Q2	$497K	Buy	552,000 +535,000	+3,147%	+$400K	0.01%	862
2024 Q1	$20.1K	Hold	17,000	–	–	﹤0.01%	1291
2023 Q4	$15.5K	Hold	17,000	–	–	﹤0.01%	1344
2023 Q3	$14.2K	Hold	17,000	–	–	﹤0.01%	1350
2023 Q2	$20.4K	Sell	17,000 -178,900	-91%	-$223K	﹤0.01%	1363
2023 Q1	$247K	Buy	+195,900	New	+$375K	0.01%	1064

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Bridgeway Capital Management's GOSS Position: Q2 2026 in Review

Bridgeway Capital Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 16,000 shares — an estimated $5.26K sold.

Bridgeway Capital Management first reported a position in GOSS in Q1 2023 and held it in 13 quarters. The position peaked at $883K in Q3 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Bridgeway Capital Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
Bridgeway Capital Management sold 16,000 Gossamer Bio shares in Q2 2026, an estimated $5.26K.
Bridgeway Capital Management first reported a position in Gossamer Bio in Q1 2023 and held it in 13 quarters.
Bridgeway Capital Management's Gossamer Bio position peaked at $883K in Q3 2025.
170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.